A

AveXis, Inc.

230 employees

AveXis is a Biotech company is focused on developing gene therapy for patients with rare and life-threatening neurological genetic diseases.

Basic info

Industry

biotechnology

Sectors

Biotechnology
Health Care
Genetics
Medical

Date founded

2010

Funding rounds raised

Total raised

$65M

from 7 investors over 7 rounds

A

AveXis, Inc. raised $100K on January 1, 2019

Investors: North Carolina Biotechnology Center (NCBiotech)

A

AveXis, Inc. raised $65M on September 8, 2015

Investors: Venrock, T. Rowe Price, RA Capital Management, L.P., QVT Financial LLP, Foresite Capital and RTW Investments, LP

FAQ